Aprea Therapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
APRE on Nasdaq
Industry
Pharmaceutical Preparations
Location
3805 Old Easton Road, Doylestown, PA

Insiders trading volume in the past year

Aprea Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Oren Gilad President/CEO, Director $1.31M +$20.2K +1.57% Oct 23, 2024
Marc Duey Director $1.07M +$103K +10.6% Oct 18, 2024
Christian Schade Director $976K Jul 28, 2022
Scott M. Coiante SVP, Chief Financial Officer $534K Jul 28, 2022
Eyal C. Attar SVP, Chief Medical Officer, Director $211K Jun 3, 2022
Gregory Alan Korbel SVP, Chief Operating Officer $168K Jul 28, 2022
Lars B. Abrahmsen SVP, Chief Scientific Officer $161K Mar 10, 2022
Rifat Pamukcu Director $135K Jun 20, 2024
Bernd R. Seizinger Director $120K +$76.8K +178% Oct 11, 2024
John B. Henneman III Director $67K +$50K +295% Jun 20, 2024
Nadeem Q. Mirza Chief Medical Officer $49.1K May 1, 2024
John Hamill SrVP/CFO/Prin Fin & Acct Ofcr $47.7K +$8.66K +22.2% Oct 11, 2024
Michael Aaron Kelly Director $17K Jun 30, 2021
Fouad Namouni Director $17K Jun 30, 2021
Richard Peters Director $15.1K Jun 20, 2024
Michael Grissinger Director $13.4K Jun 20, 2024
Gabriela Gruia Director May 5, 2023
Jean Pierre Bizzari Director Aug 23, 2023

Recent Insider Transactions by Companies or Individuals for Aprea Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.